hematology aplasticanemia-120108092936-phpapp02

32
Aplastic Anemia Download more documents and slide shows on The Medical Post [ www.themedicalpost.net ] Dr. Kalpana Malla MD Pediatrics Manipal Teaching Hospital

Upload: inga-tverdohleb

Post on 14-Jun-2015

241 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Hematology aplasticanemia-120108092936-phpapp02

Aplastic Anemia

Download more documents and slide shows on The Medical Post [ www.themedicalpost.net ]

Dr. Kalpana MallaMD Pediatrics

Manipal Teaching Hospital

Page 2: Hematology aplasticanemia-120108092936-phpapp02

PANCYTOPENIA:

• Simultaneous presence of anaemia, leukopenia, thrombocytopenia

• Causes: aplastic anemia Subleukemic leukemia cytotoxic drugs radiotherapy bone marrow infiltration hypersplenism megaloblastosis SLE

Page 3: Hematology aplasticanemia-120108092936-phpapp02

APLASTIC ANEMIA:

• Failure of two or more cell lines• Anaemia, leukopenia,

thrombocytopenia + Hypoplasia or aplasia of the marrow

Page 4: Hematology aplasticanemia-120108092936-phpapp02

Pathology:• Reduction in the amount of haemopoietic

tissue- inability to produce mature cells for discharge into the bloodstream

• Patchy areas of normo/hypercellularity betn areas of hypocellularity

Page 5: Hematology aplasticanemia-120108092936-phpapp02

CLASSIFICATION:

• Idiopathic• Secondary: idiosyncratic drug reaction chemical exposure infectious hepatitis paroxysmal nocturnal haemoglobinuria• Constitutional

Page 6: Hematology aplasticanemia-120108092936-phpapp02

CLASSIFICATION

CONSTITUTIONAL/CONGENITAL• Diamond-Blackfan syndrome• Shwachmann-Diamond syndrome• Fanconi anemia• Dyskeratosis Congenita• TAR (thrombocytopenia with absent radii)• Amegakaryocytic thrombocytopenia

Page 7: Hematology aplasticanemia-120108092936-phpapp02

FANCONI ANEMIA

• Familial • AR• M:F=1.3:1• Onset in 1st decade of life• Diminished capacity for DNA repair and

increased random chromosome breakage during mitosis

Page 8: Hematology aplasticanemia-120108092936-phpapp02

C/F:

• Facies – microphthalmia,depressed nasal bridge,epicanthic fold,micrognathia

• Hyperpigmentation, café-au-lait spots• Absent / hypoplastic thumb• Skeletal and renal lesions• Short stature, • Microcephaly , subnormal intelligence• Hypogonadism,ano malies of urinary tract• Predisposition to leukemias• Poor prognosis

Page 9: Hematology aplasticanemia-120108092936-phpapp02

DYSKERATOSIS CONGENITA

• X-linked, AR, AD• M:F= 4.3:1• Hyperpigmentation• Nail dystrophy, early loss of teeth• Leukoplakia• Ocular abnormalities: cataract etc• Short stature but No skeletal/renal lesions (diff

from FA)

Page 10: Hematology aplasticanemia-120108092936-phpapp02

DIAMOND BLACKFAN SYNDROME

• Congenital pure red cell aplasia• AD, AR, Sporadic• Familial in 15 %• 90 % diagnosed in 1st year of life• Intrinsic defect in RBC, early apoptosis• Macrocytic anemia, reticulocytopenia,

absence of RBC precursors in an otherwise normocellular bone marrow

Page 11: Hematology aplasticanemia-120108092936-phpapp02

DIAMOND BLACKFAN SYNDROME

• Eye - Wide set eyes, blue sclera,glaucoma,epicanthic fold,cataract,strabismus

• Thick upper,cleft lip palate in some cases• lip,intelligent expression• Upperlimb anomalies – flattening of thenar

eminence, Triphalangeal thumb

Page 12: Hematology aplasticanemia-120108092936-phpapp02

C/F:

• Profound anemia at 2-6 months of age• Short stature• Renal anomalies and hypogonadism maybe

present

Page 13: Hematology aplasticanemia-120108092936-phpapp02

ACQUIRED APLASTIC ANEMIA - CAUSES

• Radiation• Drugs and chemicals - chemotherapy - benzene - chloramphenicol - antiepileptics• Viruses: - CMV - EBV - Hep B, C,D - HIV

• Immune diseases: - eosinophilic fascitis - thymoma • Pregnancy• PNH• Marrow replacement: - leukemia - myelofibrosis - myelodysplasia

Page 14: Hematology aplasticanemia-120108092936-phpapp02

PATHOPHYSIOLOGY

• Direct destruction of haemopoietic progenitors

• Disruption of marrow micro-environment• Immune –mediated suppression of marrow

elements Cytotoxic T cells in blood and marrow

release gamma IFN and TNF -> inhibit early and late progenitor cells

Page 15: Hematology aplasticanemia-120108092936-phpapp02

Pathology:

• Hallmark: peripheral pancytopenia with hypoplastic/ aplastic bone marrow

Page 16: Hematology aplasticanemia-120108092936-phpapp02

CLINICAL FEATURESRBC (anemia)• Progressive and persistent pallor• Anemia related symptoms WBC (Leucopenia/neutropenia)• Prone to infections - Pyodermas, OM,

pneumonia, UTI, GI infections, sepsisPlatelets (Thrombocytopenia)• Petechiae, purpura, ecchymoses• Hematemesis, hematuria, epistaxis, gingival bleed• IC bleed- headache, irritability, drowsiness, coma

Page 17: Hematology aplasticanemia-120108092936-phpapp02

NO HEPATOMEGALY

NO SPLENOMEGALY

NO LYMPHADENOPATHY

Failure of entire RES. No extramedullary hematopoesis

Page 18: Hematology aplasticanemia-120108092936-phpapp02

Blood picture:

• Anemia-normocytic, normochromic • Leukopenia (neutropenia)• Relative lymphocytosis• Thrombocytopenia• Absolute reticulocyte count low• Mild to moderate anisopoikilocytosis

Page 19: Hematology aplasticanemia-120108092936-phpapp02

Other investigations

• BM : dry aspirate, hypocellular with fat (>70% yellow marrow)

Page 20: Hematology aplasticanemia-120108092936-phpapp02

SEVERITYSEVERE APLASTIC ANEMIA• Granulocyte count <500/cu.mm• Platelet count <20,000/cu.mm• Reticulocytes <1%• BM < 25% of hematopoeitic cells

VERY SEVERE/ EXTREME APLASTIC ANEMIA• Above + Granulocyte count <200/cu.mm

Page 21: Hematology aplasticanemia-120108092936-phpapp02

DIFFERENTIAL DIAGNOSIS• ITP• LEUKEMIA• MYELOID METAPLASIA

Page 22: Hematology aplasticanemia-120108092936-phpapp02

Management:

• Identification and elimination of underlying cause

• Supportive therapy:1. Red cell transfusion for anemia2. Prevention and treatment of haemorrhage3. Prevention and treatment of infection

Page 23: Hematology aplasticanemia-120108092936-phpapp02

SUPPORTIVE CARE

• Prophylactic antibiotics• If infection: cephalosporins + aminoglycosides

+ metronidazole• Antifungals: amphotericin B, fluconazole (if

fever >10 days despite antibiotics)

Page 24: Hematology aplasticanemia-120108092936-phpapp02

THERAPY

DEFINITIVE

• BONE MARROW TRANSPLANTATION• IMMUNOSUPPRESSION

Page 25: Hematology aplasticanemia-120108092936-phpapp02

BONE MARROW TRANSPLANTATION

• Treatment of choice• HLA matched donor. Usually siblings• Long term survival rates: 60-70%• Donor stem cells > 4 X 108 cells/kg

Page 26: Hematology aplasticanemia-120108092936-phpapp02

IMMUNOSUPPRESSION

• Antithymocyte globulin (ATG)• Antilymphocyte glubulin (ALG)• Cyclosporin• Intensive immunosupression :

cyclophosphamide• Corticosteroids

Page 27: Hematology aplasticanemia-120108092936-phpapp02

ATG administration:

• IV administration of Ig preparations containing antibody to human thymocytes

• Improvement in haematological indices in one-half of subjects

• Anaphylaxis

Page 28: Hematology aplasticanemia-120108092936-phpapp02

ATG AND ALG

• Dose : 40 mg/kg/day X 4 days• Hematologic response rate 45%• Survival rate 60%• Side effects: serum sickness

Page 29: Hematology aplasticanemia-120108092936-phpapp02

ANDROGENS

• No longer have primary role• Increase erythopoietin producion• Stimulate erythroid stem cells• Increase Hb levels in normal males methyl testosterone, testesterone enanthate,

oxymetholone, danazolOral dose : 2-5mg/kg/day, IM dose: 1-2mg/kg/wkSide effects: cholestatic jaundice, masculinization

Page 30: Hematology aplasticanemia-120108092936-phpapp02

Corticosteroids:

• High dose steroids combined with anabolic agents

• Uncertain benefits• Side-effects

Page 31: Hematology aplasticanemia-120108092936-phpapp02

HAEMATOPOIETIC GROWTH FACTORS

• GM-CSF• G-CSF• IL-3• IL-1• IL-6

Page 32: Hematology aplasticanemia-120108092936-phpapp02

Thank youDownload more documents and slide shows on The

Medical Post [ www.themedicalpost.net ]